An Update on the Dopaminergic Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder | Zendy

Wayne A. Hening | Zendy; Richard P. Allen | Zendy; Christopher J. Earley | Zendy; Daniel L. Picchietti | Zendy; Michael H. Silber | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

An Update on the Dopaminergic Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder

Author(s) -

Wayne A. Hening,

Richard P. Allen,

Christopher J. Earley,

Daniel L. Picchietti,

Michael H. Silber

Publication year - 2004

Publication title -

sleep

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.222

H-Index - 207

eISSN - 1550-9109

pISSN - 0161-8105

DOI - 10.1093/sleep/27.3.560

Subject(s) - ropinirole , pramipexole , restless legs syndrome , dopaminergic , pergolide , levodopa , dopamine agonist , medicine , cabergoline , selegiline , physical medicine and rehabilitation , psychology , parkinson's disease , dopamine , psychiatry , insomnia , disease , prolactin , hormone

This paper reviews evidence from April, 1998 through April 2002 for the dopaminergic treatment of the restless legs syndrome (RLS) and periodic limb movement disorder (PLMD). There has been increased study of dopaminergic agents for the treatment of these conditions since publication of a review paper and practice parameters that covered all types of medical treatment of RLS and PLMD in 1999. For this reason, the Restless Legs Syndrome Task Force and the Standards of Practice Committee decided to update the evidence on dopaminergic treatment of these conditions. This paper reviews the literature on levodopa, dopaminergic agonists (pergolide, pramipexole, ropinirole, talipexole, cabergoline, piribidel, DHEC), and other dopaminergic agents (amantadine, selegiline).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research